Number of people who responded to POLIVY

People who received POLIVY+BR had a complete remission or a partial remission more often compared with those who received BR by itself.

More people had complete remission with POLIVY+BR after finishing treatment*

Complete remission in people who received either POLIVY+BR or BR by itself:

*Doctors in the study checked response to treatment 6 to 8 weeks after Day 1 of cycle 6 or last study treatment.

How long people responded to POLIVY

63% of the people who received POLIVY+BR had a complete or partial remission at some point in the study (25 out of 40), compared with 25% of those who received BR by itself (10 out of 40)

Nearly 1 in 2 people who responded to treatment with POLIVY+BR were in remission for a year or more

Duration of response (DoR) in people who responded to treatment with POLIVY+BR:

Of the 10 people who responded to BR treatment by itself, 20% had a DoR of at least 12 months (2 out of 10), and 30% had a DoR of at least 6 months (3 out of 10)

Duration of response (DoR) is the length of time a person is in remission, from when they first respond to treatment to when the disease gets worse. DoR includes people who have had a complete remission or partial remission at any time in the study.

Talk with your doctor for additional data about POLIVY+BR and what it may mean for your prognosis

How Does POLIVY Work?

POLIVY™ (polatuzumab vedotin-piiq) icon for how it may work

Learn about how POLIVY was designed to treat R/R DLBCL

How Is POLIVY Administered?

POLIVY™ (polatuzumab vedotin-piiq) icon for infusion process

See the infusion process and dosing schedule for POLIVY+BR

Possible Side Effects of POLIVY

POLIVY™ (polatuzumab vedotin-piiq) icon for possible side effects

Learn about side effects most frequently seen with POLIVY+BR